In patients with stable CAD or CAD risk equivalents who have reduced left ventricular systolic function

In patients with stable CAD or CAD risk equivalents who have reduced left ventricular systolic function , what is the comparative effectiveness of ACE inhibitors or ARBs added to standard medical therapy when compared to standard medical therapy alone in